Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Glaukos Corp    GKOS

GLAUKOS CORP

(GKOS)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/15/2019 08/16/2019 08/19/2019 08/20/2019 08/21/2019 Date
60.7(c) 62.94(c) 63.74(c) 63(c) 63.03(c) Last
295 702 384 618 535 007 534 485 389 442 Volume
+0.30% +3.69% +1.27% -1.16% +0.05% Change
More quotes
Financials (USD)
Sales 2019 231 M
EBIT 2019 -19,3 M
Net income 2019 -17,9 M
Finance 2019 40,7 M
Yield 2019 -
Sales 2020 275 M
EBIT 2020 0,41 M
Net income 2020 -0,40 M
Finance 2020 192 M
Yield 2020 -
P/E ratio 2019 -124x
P/E ratio 2020 -5 158x
EV / Sales2019 9,85x
EV / Sales2020 7,74x
Capitalization 2 322 M
More Financials
Company
Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted... 
More about the company
Surperformance© ratings of Glaukos Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAUKOS CORP
08/08ALERT : Rowley Law PLLC is Investigating Proposed Acquisition of Avedro, Inc.
PR
08/08GLAUKOS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
08/08GLAUKOS CORP : Entry into a Material Definitive Agreement, Change in Directors o..
AQ
08/07GLAUKOS : 2Q Earnings Snapshot
AQ
08/07GLAUKOS CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/07GLAUKOS CORP : Results of Operations and Financial Condition, Financial Statemen..
AQ
08/07GLAUKOS CORPORATION : Announces Second Quarter 2019 Financial Results
BU
08/07GLAUKOS : and Avedro Announce Definitive Acquisition Agreement
BU
07/22GLAUKOS : Announces Global Licensing Agreement With Intratus, Inc.
BU
07/22GLAUKOS CORPORATION : to Release Second Quarter 2019 Financial Results after Mar..
BU
More news
Sector news : Medical Devices & Implants
08/20Medtronic on Pace for Record High After 1Q Results -- Data Talk
DJ
08/20GLOBAL MARKETS LIVE : Saudi Aramco, Baidu, Apple, Elanco…
08/20MEDTRONIC : Correction to Medtronic Earnings Article
DJ
08/20MEDTRONIC : Beats Analysts' Expectations for 1Q Revenue, Adjusted EPS
DJ
08/20Global Stocks Waver Amid Uncertainty on Rates, Trade Talks
DJ
More sector news : Medical Devices & Implants
Chart GLAUKOS CORP
Duration : Period :
Glaukos Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAUKOS CORP
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 79,56  $
Last Close Price 63,03  $
Spread / Highest target 50,7%
Spread / Average Target 26,2%
Spread / Lowest Target -0,05%
EPS Revisions
Managers
NameTitle
Thomas William Burns President, Chief Executive Officer & Director
William J. Link Chairman
Chris M. Calcaterra Chief Operating Officer
Joseph E. Gilliam CFO & Senior VP-Corporate Development
L. Jay Katz Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
GLAUKOS CORP12.21%2 322
STRYKER CORPORATION39.73%81 718
SMITH & NEPHEW32.86%20 610
WRIGHT MEDICAL GROUP NV-18.30%2 817
INSPIRE MEDICAL SYSTEMS INC59.83%1 615
JAPAN LIFELINE CO., LTD.26.89%1 290